Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-06-30
1999-11-16
Dees, Jose' G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514255, 514256, 514254, 514267, 514269, 514274, 514249, 544319, 544324, 544336, 544349, 544253, 544283, 544287, 544298, 544284, 544353, 544354, 544355, C07D41712, C07D23902, C07D24100, A61K 31505
Patent
active
059858842
ABSTRACT:
The present invention relates to novel antidiabetic compounds, their tautomeric forms, their derivatives, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. This invention particularly relates to novel azolidinedione derivatives of the general formula (I), and their pharmaceutically acceptable salts, pharmaceutically acceptable solvates and pharmaceutical compositions containing them. ##STR1##
REFERENCES:
patent: 4342771 (1982-08-01), Schnur
patent: 4367234 (1983-01-01), Schnur
patent: 4725610 (1988-02-01), Meguro
patent: 4873255 (1989-10-01), Yoshioka
patent: 5002953 (1991-03-01), Hindley
patent: 5036079 (1991-07-01), Clark
patent: 5037842 (1991-08-01), Goldstein
patent: 5130379 (1992-07-01), Clark
patent: 5153210 (1992-10-01), Ainsworth
patent: 5296605 (1994-03-01), De Nanteuil
patent: 5330999 (1994-07-01), De Nanteuil
patent: 5420146 (1995-05-01), Malamas
patent: 5468762 (1995-11-01), Malamas
patent: 5478851 (1995-12-01), Cantello
patent: 5478852 (1995-12-01), Olefsky
patent: 5478853 (1995-12-01), Regnier
patent: 5480896 (1996-01-01), Malamas
patent: 5498621 (1996-03-01), Dow
patent: 5521201 (1996-05-01), Hindley
patent: 5521202 (1996-05-01), Yano
patent: 5710152 (1998-01-01), Nagao et al.
Behavioral Brain Research, 75 (1996) pp. 1-11, Messler, et al.
Chemical Pharamceutical Bulletin, vol. 30 No. 10, 1982 pp. 3580-3600, Takasi Sohda, et al.
D.A. Clark et al., "Substituted Dihydrobenzeopran . . . ", J. Med. Chem. 1991, 34, 319-325.
R.L. Dow et al., "Benzyloxzolidine-2,4-diones . . . ", J. Med. Chem. 1991, 34, 1538-1544.
S.W. Goldstein et al., "Hydroxyurea Derivatives . . . ", J. Med. Chem. 1993, 36, 2238-2240.
B. Hulin et al., "Novel Thiazolidine . . . ", J. Med. Chem. 1992, vol. 35 No. 10, 1853-1864.
Journal of Medicinal Chemistry, vol. 37, No. 23, 1994, Cantello et al., pp. 3977-3985.
T. Sohda et al., "Studies on Antidiabetic . . . ", J. Med. Chem., 1992, vol. 35, No. 14, 2617-2626.
Khan, A., et al., "Synthesis and Antibacterial Activity of Some New 2-aryloxymethyl-3substituted-quinazollin-4 (3H)-ones" Pharmazie vol. 43, No. 12, pp. 864-865, 1988.
Chemical Abstracts, vol. 93, No. 17, Oct. 27, 1980, No. 168217.
Shukla, J.S., et al. "Synthesis of 2-phenoxymethyl-3-(2'-pyridyl/thiazolyl)-4-quinazolones as Possible Antifertility Drugs" Indian Journal Chemical, vol. 17B, No. 6, pp. 651-652, Jun. 1979.
Husain, M.I., et al., "Some New 2-aryloxymethyl-3-.alpha.-substituted carboxymethyl-6, 8 substituted 4-quinazolones as Possible Anticonvulsants", Pharmazie, vol. 37, No. 6, 1982, pp. 408-410.
English Translation of JP-A-0912575.
G. De Nanteuil, "Euglygaemic and Biological Activities of Novel Thiazolidine-2,4-dione Derivatives" Arzneittel Forschung/Drug Design, vol. 45, No. II, 1995, pp. 1176-1181.
Whitcomb, R.W., "Thiazolidinediones", Expert Opinion on Investigational Drugs, vol. 4, No. 12, Dec. 1995, pp. 1299-1309.
Chakrabarti Ranjan
Gurram Ranga Madhavan
Lohray Braj Bhushan
Lohray Vidya Bhushan
Pakala Sarma K. S.
Dees Jos,e G.
Dr. Reddy's Research Foundation
Qazi Sabiha N.
Reddy-Cheminor Inc.
LandOfFree
Heterocyclic compounds, process for their preparation and pharma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic compounds, process for their preparation and pharma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic compounds, process for their preparation and pharma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1325052